Literature DB >> 23686364

Morphometry analysis of lymphatics in pulmonary adenocarcinomas with a lepidic growth pattern.

Aurélie Sannier1, Marianne Kambouchner, Claire Danel, Patrice Callard, Jean-François Bernaudin.   

Abstract

Lymph vessels play an important role in tumor progression. Pulmonary adenocarcinomas, accounting for half of non-small-cell lung carcinomas, compose a spectrum of histological types, exclusively or without a lepidic growth pattern (LGP) along preserved interalveolar septa. In that context, this study was designed to investigate the lymphatic vascular pattern associated with LGP and the concomitant invasive component of pulmonary adenocarcinomas. Using the D2-40 monoclonal antibody as a marker of lymphatic endothelial cells, the lymphatic vessel density (LVD) and vessel-area fraction (LVAF) were morphometrically analyzed in four adenocarcinomas in situ (AIS) and the LGP of eight invasive adenocarcinomas (LPIA), and compared with their invasive pattern (IPIA). LVD in AIS (2.1 ± 0.7 mm(-2)) and LPIA (2.4 ± 1 mm(-2)) were significantly lower than that in IPIA (14.9 ± 13.6 mm(-2)) (p=0.001). Moreover, the lymphatic vascular pattern in LGP was similar to that of normal lung, with isolated small lymphatic vessels within the interalveolar septa. Our results showing the scarcity of lymphatics in LGP suggest an absence of septal lymphangiogenesis associated with the LGP pattern in lung adenocarcinomas, which could explain, at least partially, the better prognosis observed in tumors with exclusive or predominant lepidic spread compared with other subtypes.

Entities:  

Keywords:  D2-40; adenocarcinoma; lepidic; lung; lymphangiogenesis

Mesh:

Year:  2013        PMID: 23686364      PMCID: PMC3724389          DOI: 10.1369/0022155413492538

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  24 in total

1.  Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma.

Authors:  T Niki; S Iba; T Yamada; Y Matsuno; B Enholm; S Hirohashi
Journal:  J Pathol       Date:  2001-04       Impact factor: 7.996

2.  Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.

Authors:  Masami Ito; Genichiro Ishii; Kanji Nagai; Ryo Maeda; Yasutaka Nakano; Atsushi Ochiai
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

3.  Lymphatic microvessel density using D2-40 is associated with nodal metastasis in non-small cell lung cancer.

Authors:  Iwao Takanami
Journal:  Oncol Rep       Date:  2006-02       Impact factor: 3.906

4.  Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach.

Authors:  Evangelos Evangelou; Panayiotis A Kyzas; Thomas A Trikalinos
Journal:  Mod Pathol       Date:  2005-11       Impact factor: 7.842

5.  Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer.

Authors:  Ferenc Renyi-Vamos; Jozsef Tovari; Janos Fillinger; Jozsef Timar; Sandor Paku; Istvan Kenessey; Gyula Ostoros; Laszlo Agocs; Ibolya Soltesz; Balazs Dome
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

6.  LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.

Authors:  M I Koukourakis; A Giatromanolaki; E Sivridis; C Simopoulos; K C Gatter; A L Harris; D G Jackson
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

7.  Expression of hypoxia-inducible factor-1 alpha and its prognostic significance in small-sized adenocarcinomas of the lung.

Authors:  Sotarou Enatsu; Akinori Iwasaki; Takayuki Shirakusa; Makoto Hamasaki; Kazuki Nabeshima; Hiroshi Iwasaki; Motomu Kuroki; Masahide Kuroki
Journal:  Eur J Cardiothorac Surg       Date:  2006-05-03       Impact factor: 4.191

8.  Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.

Authors:  Pierre Saintigny; Marianne Kambouchner; Madani Ly; Noëlia Gomes; Odile Sainte-Catherine; Roger Vassy; Sébastien Czernichow; Philippe Letoumelin; Jean-Luc Breau; Jean-François Bernaudin; Michel Kraemer
Journal:  Lung Cancer       Date:  2007-08-07       Impact factor: 5.705

9.  Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.

Authors:  Reda S Saad; Yulin Liu; Helen Han; Rodney J Landreneau; Jan F Silverman
Journal:  Mod Pathol       Date:  2004-10       Impact factor: 7.842

10.  First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours.

Authors:  I Van der Auwera; Y Cao; J C Tille; M S Pepper; D G Jackson; S B Fox; A L Harris; L Y Dirix; P B Vermeulen
Journal:  Br J Cancer       Date:  2006-11-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.